NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kanvas Biosciences

Kanvas Biosciences

Private
Princeton, New JerseyHealthcare & Life Scienceshttps://www.kanvasbio.com/

Last Round

Series A

May 6, 2026

Total Funding Raised

$72.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Kanvas Biosciences is a spatial biology company that develops microbiome drug screening, discovery, and manufacturing platforms to accelerate the development of next-generation live biotherapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

microbiome therapeuticsspatial biologyimmuno-oncologysynthetic microbiomelive biotherapeutic productsLBPmicrobiome drug discoveryAI drug discoverycancer immunotherapyspatial imagingmetagenomicsgut microbiomeprecision medicinebiotech platformbug drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kanvas Biosciences Comps

Public and private peers based on sector, stage, and business model.

Kanvas Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kanvas Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 6, 2026
SeedJul 1, 2024
Pre SeedJun 22, 2023

Key People

Founding team and executive leadership

Matthew Cheng

Chief Executive Officer, Co-Founder

Founding Team

Hao S.

Chief Technology Officer

Executive Team

Kanvas Biosciences Investors

Notable investors and investment history

Kanvas Biosciences investors
InvestorRounds
Zeon VenturesSeries A
Kicker VenturesSeries A
GaingelsSeries A
Triple Impact CapitalSeries A, Pre Seed
Uncommon DenominatorSeries A, Pre Seed
Athos KGSeries A
Germin8 VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 40% MoM.

  • May 6, 2026

    $48M round led by DCVC and Lions Capital.

Kanvas Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kanvas Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kanvas Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersPrinceton, New Jersey
Employee Range42
Year Founded2020
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.